Novartis AG (NVS) Stock Overview
Explore Novartis AG’s financial performance, market position, analyst ratings, and future outlook.
Novartis AG (NVS)
Key Financials
Key Financials
Market Cap
301.9B
P/E Ratio
23.52
EPS (TTM)
$8.69
ROE
0.30%
NVS Stock Analysis & Investment Overview (NYSE)
Our AI-powered analysis of Novartis AG (NYSE: NVS) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of A, Novartis AG's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of NVS on the NYSE shows an RSI of 53.34, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $169.96 for the NYSE listing.
Key metrics behind Novartis AG's NYSE-traded stock include a P/E ratio of 23.52 and a market capitalization of 301.9B. Combined with our AI analysis, these give both institutional and retail investors a clear view of NVS on the NYSE.